Literature DB >> 9421082

Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas.

I Alvarado-Cabrero1, S S Navani, R H Young, R E Scully.   

Abstract

Twenty tumors that were primary in the tubal fimbriae are reported. They were found in patients aged 17 to 83 (average 57) years. All were of mullerian type. Nine tumors were benign (eight adenofibromas, one cystadenoma), of which seven were serous and two, endometrioid. Two tumors were borderline, a serous papillary cystic tumor of borderline malignancy and an endometrioid adenofibroma of borderline malignancy. Nine tumors were carcinomas, of which four were serous, three endometrioid, and two undifferentiated. Follow-up information was available for six patients with carcinoma. One with serous carcinoma was well at 1 year; a second had ascites with malignant cytologic features nine years postoperatively and is currently on chemotherapy. One patient with endometrioid carcinoma was alive without disease after 8 years, and the other died of tumor at 6.5 years. One patient with undifferentiated carcinoma was alive without disease at 5 years and the other died of disease at eight months. The occurrence of fallopian tube tumors that arise in the fimbriae has received scanty attention in the literature. A fimbrial origin for the tumors is often overlooked initially. Carcinomas confined to the fimbriae cannot be adequately staged according to the current staging system of the International Federation of Gynecology and Obstetrics. It is proposed that they be placed in a new category, Stage I(F), because the tumor cells are exposed directly to the peritoneal cavity even though they do not invade the tubal wall. Although experience is limited it appears that they may have a worse prognosis than Stage I tubal tumors that are nonfimbrial.

Entities:  

Mesh:

Year:  1997        PMID: 9421082     DOI: 10.1097/00004347-199707000-00001

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  14 in total

1.  Clear-cell adenoma of the fallopian tube, a rare tumor of the tubal mucosa.

Authors:  Günther Bayer; Johannes Pammer; Reinhard Horvat; Peter Birner
Journal:  Virchows Arch       Date:  2004-05-13       Impact factor: 4.064

2.  Paratubal serous borderline tumor.

Authors:  You-Jung Shin; Ji-Young Kim; Hee Jin Lee; Jeong-Yeol Park; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

3.  Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  Edward J Pavlik
Journal:  Womens Health (Lond)       Date:  2016-09-05

Review 4.  Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Authors:  Christopher P Crum; Ronny Drapkin; David Kindelberger; Fabiola Medeiros; Alexander Miron; Yonghee Lee
Journal:  Clin Med Res       Date:  2007-03

5.  Serous borderline tumor of the fallopian tube.

Authors:  So Mi Choi; Min Youp Choi; Woo Dae Kang; Ho Sun Choi; Seok Mo Kim
Journal:  Obstet Gynecol Sci       Date:  2014-07-15

6.  Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?

Authors:  Ibrahim Kulac; Alp Usubutun
Journal:  J Gynecol Oncol       Date:  2013-04-05       Impact factor: 4.401

7.  Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report.

Authors:  Maja Krasevic; Teodora Stankovic; Oleg Petrovic; Neda Smiljan-Severinski
Journal:  BMC Cancer       Date:  2005-10-07       Impact factor: 4.430

8.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

9.  A Resident's Perspective of Ovarian Cancer.

Authors:  Christopher G Smith
Journal:  Diagnostics (Basel)       Date:  2017-04-27

10.  Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?

Authors:  Brent D Kerger; Robert C James; David A Galbraith
Journal:  Front Genet       Date:  2014-05-30       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.